Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study)-Reference-Cited by-同舟云学术

Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study)

Published:2018-12 Issue:3 Volume:129 Page:471-478
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Vallard A.,Rancoule C.,Espenel S.,Garcia M.-A.,Langrand-Escure J.,He M.Y.,Ben Mrad M.,El Meddeb Hamrouni A.,Ouni S.,Trone J.-C.,Rehailia-Blanchard A.,Guillaume E.,Vial N.,Riocreux C.,Guy J.-B.,Magné N.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference52 articles.

1. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions;Bentzen;Nat Clin Pract Oncol,2007

2. Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies;Blaheta;Med Res Rev,2005

3. Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?;Chargari;Lancet Oncol,2009

4. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3;Chen;J Neurochem,1999

5. Selective β2-AR blockage suppresses colorectal cancer growth through regulation of EGFR-Akt/ERK1/2 signaling, G1-phase arrest, and apoptosis;Chin;J Cell Physiol,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing toxicities of curative radiotherapy combined with concomitant non anti-cancer drugs: A sub-analysis of the prospective epidemiological RIT trial;Radiotherapy and Oncology;2022-03